278 related articles for article (PubMed ID: 24942731)
1. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Moreno E; Andradas C; Medrano M; Caffarel MM; Pérez-Gómez E; Blasco-Benito S; Gómez-Cañas M; Pazos MR; Irving AJ; Lluís C; Canela EI; Fernández-Ruiz J; Guzmán M; McCormick PJ; Sánchez C
J Biol Chem; 2014 Aug; 289(32):21960-72. PubMed ID: 24942731
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Gene and Protein Expression of Cannabinoid CB
García-Gutiérrez MS; Navarrete F; Navarro G; Reyes-Resina I; Franco R; Lanciego JL; Giner S; Manzanares J
Neurotherapeutics; 2018 Jul; 15(3):796-806. PubMed ID: 29435814
[TBL] [Abstract][Full Text] [Related]
3. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
Balenga NA; Martínez-Pinilla E; Kargl J; Schröder R; Peinhaupt M; Platzer W; Bálint Z; Zamarbide M; Dopeso-Reyes IG; Ricobaraza A; Pérez-Ortiz JM; Kostenis E; Waldhoer M; Heinemann A; Franco R
Br J Pharmacol; 2014 Dec; 171(23):5387-406. PubMed ID: 25048571
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of HER2-CB
Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
[TBL] [Abstract][Full Text] [Related]
7. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
[TBL] [Abstract][Full Text] [Related]
8. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
[TBL] [Abstract][Full Text] [Related]
9. Expression of GPR55 and either cannabinoid CB
Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
[TBL] [Abstract][Full Text] [Related]
10. Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay.
Martínez-Pinilla E; Rabal O; Reyes-Resina I; Zamarbide M; Navarro G; Sánchez-Arias JA; de Miguel I; Lanciego JL; Oyarzabal J; Franco R
J Pharmacol Exp Ther; 2016 Sep; 358(3):580-7. PubMed ID: 27358483
[TBL] [Abstract][Full Text] [Related]
11. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
[TBL] [Abstract][Full Text] [Related]
12. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
13. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
Balenga NA; Aflaki E; Kargl J; Platzer W; Schröder R; Blättermann S; Kostenis E; Brown AJ; Heinemann A; Waldhoer M
Cell Res; 2011 Oct; 21(10):1452-69. PubMed ID: 21467997
[TBL] [Abstract][Full Text] [Related]
14. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
Yang H; Zhou J; Lehmann C
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
[TBL] [Abstract][Full Text] [Related]
15. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
Hu G; Ren G; Shi Y
Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
[TBL] [Abstract][Full Text] [Related]
16. The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells.
Akimov MG; Gretskaya NM; Dudina PV; Sherstyanykh GD; Zinchenko GN; Serova OV; Degtyaryova KO; Deyev IE; Bezuglov VV
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982628
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and functional role of cannabinoid genes in alcohol users.
Agudelo M; Yndart A; Morrison M; Figueroa G; Muñoz K; Samikkannu T; Nair MP
Drug Alcohol Depend; 2013 Dec; 133(2):789-93. PubMed ID: 24060590
[TBL] [Abstract][Full Text] [Related]
18. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.
Pérez-Gómez E; Andradas C; Blasco-Benito S; Caffarel MM; García-Taboada E; Villa-Morales M; Moreno E; Hamann S; Martín-Villar E; Flores JM; Wenners A; Alkatout I; Klapper W; Röcken C; Bronsert P; Stickeler E; Staebler A; Bauer M; Arnold N; Soriano J; Pérez-Martínez M; Megías D; Moreno-Bueno G; Ortega-Gutiérrez S; Artola M; Vázquez-Villa H; Quintanilla M; Fernández-Piqueras J; Canela EI; McCormick PJ; Guzmán M; Sánchez C
J Natl Cancer Inst; 2015 Jun; 107(6):djv077. PubMed ID: 25855725
[TBL] [Abstract][Full Text] [Related]
19. New blood brothers: the GPR55 and CB2 partnership.
Irving A
Cell Res; 2011 Oct; 21(10):1391-2. PubMed ID: 21537344
[No Abstract] [Full Text] [Related]
20. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
